These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 8950774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus.
    Ginsberg JS, Demers C, Brill-Edwards P, Bona R, Johnston M, Wong A, Denburg JA.
    Am J Med; 1995 Apr; 98(4):379-83. PubMed ID: 7709951
    [Abstract] [Full Text] [Related]

  • 3. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.
    Forastiero RR, Kordich L, Basilotta E, Carreras LO.
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):609-16. PubMed ID: 7841319
    [Abstract] [Full Text] [Related]

  • 4. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
    Ames PR, Tommasino C, Iannaccone L, Brillante M, Cimino R, Brancaccio V.
    Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
    [Abstract] [Full Text] [Related]

  • 5. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR, Pyke S, Iannaccone L, Brancaccio V.
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Potential role of primary hypercoagulability and antiphospholipid antibody as a risk factor of acute pulmonary thromboembolism].
    Tokuyama K, Kiuchi K, Nejima J, Takayama M, Takano T, Hayakawa H.
    J Cardiol; 1998 Oct; 32(4):263-8. PubMed ID: 9833233
    [Abstract] [Full Text] [Related]

  • 8. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 9. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.
    Palosuo T, Virtamo J, Haukka J, Taylor PR, Aho K, Puurunen M, Vaarala O.
    Thromb Haemost; 1997 Oct; 78(4):1178-82. PubMed ID: 9364981
    [Abstract] [Full Text] [Related]

  • 10. Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus.
    Costallat LT, Ribeiro CC, Annichino-Bizzacchi JM.
    Sangre (Barc); 1998 Oct; 43(5):345-8. PubMed ID: 9868323
    [Abstract] [Full Text] [Related]

  • 11. Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid antibodies, and the antiphospholipid syndrome.
    Ruíz-Argüelles GJ, Ruíz-Argüelles A, Alarcón-Segovia D, Drenkard C, Villa A, Cabiedes J, Presno-Bernal M, Delezé M, Ortiz-López R, Vázquez-Prado J.
    J Rheumatol; 1991 Apr; 18(4):552-8. PubMed ID: 1829765
    [Abstract] [Full Text] [Related]

  • 12. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A, Santaolaria M, Micó L, Calvo J, Oropesa R, Villa P, Todoli J, Simó M, Corella D, Ricart JM.
    Clin Hemorheol Microcirc; 2008 Apr; 40(2):79-87. PubMed ID: 19029633
    [Abstract] [Full Text] [Related]

  • 13. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 14. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 15. [Phospholipid antibodies (lupus anticoagulant and cardiolipin antibodies). Detection and clinical significance].
    Wisløff F, Sletnes KE, Schjetlein R.
    Tidsskr Nor Laegeforen; 1993 Aug 10; 113(18):2269-72. PubMed ID: 8362396
    [Abstract] [Full Text] [Related]

  • 16. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec 10; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 17. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C, Ruangkanchanasetr P, Aimpun P, Supaporn T.
    J Med Assoc Thai; 2006 Aug 10; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [Abstract] [Full Text] [Related]

  • 18. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW, Rangarajan S, Savidge GF.
    Clin Appl Thromb Hemost; 2008 Jul 10; 14(3):332-7. PubMed ID: 17895508
    [Abstract] [Full Text] [Related]

  • 19. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
    Somers E, Magder LS, Petri M.
    J Rheumatol; 2002 Dec 10; 29(12):2531-6. PubMed ID: 12465147
    [Abstract] [Full Text] [Related]

  • 20. Acquired activated protein C resistance is associated with IgG antibodies to protein S in patients with systemic lupus erythematosus.
    Nojima J, Iwatani Y, Ichihara K, Tsuneoka H, Ishikawa T, Yanagihara M, Takano T, Hidaka Y.
    Thromb Res; 2009 May 10; 124(1):127-31. PubMed ID: 19128822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.